Hantz Financial Services’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24K Buy
161
+61
+61% +$6.63K ﹤0.01% 1881
2026
Q1
$9K Hold
100
﹤0.01% 2065
2025
Q4
$10K Buy
+100
New +$8.95K ﹤0.01% 1994
2024
Q2
Sell
-155
Closed -$3K 1134
2024
Q1
$3K Buy
155
+100
+182% +$2.14K ﹤0.01% 1011
2023
Q4
$1K Hold
55
﹤0.01% 1073
2023
Q3
$2K Hold
55
﹤0.01% 1015
2023
Q2
$2K Hold
55
﹤0.01% 984
2023
Q1
$1K Hold
55
﹤0.01% 1054
2022
Q4
$1K Hold
55
﹤0.01% 1017
2022
Q3
$3K Hold
55
﹤0.01% 915
2022
Q2
$2K Hold
55
﹤0.01% 930
2022
Q1
$4K Buy
+55
New +$3.76K ﹤0.01% 900

Other funds holding GH

Hantz Financial Services's GH Position: Q2 2026 in Review

Hantz Financial Services increased its Guardant Health (GH) stake by 61% in Q2 2026, buying an estimated $6.63K and bringing the position to 161 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #1881.

Hantz Financial Services first reported a position in GH in Q1 2022 and has held it in 12 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Hantz Financial Services held 161 shares of Guardant Health worth $24K as of Q2 2026.
  • Hantz Financial Services bought 61 Guardant Health shares in Q2 2026, an estimated $6.63K.
  • Guardant Health made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1881 holding.
  • Hantz Financial Services first reported a position in Guardant Health in Q1 2022 and has held it in 12 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.